seagen-inc
Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly US$ 40 billion.

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal
IHSG
6.862,26
0.34%
22,92
LQ45
941,14
0.50%
4,65
USD/IDR
14.992
0,09
EMAS
1.029.000
0,19%